Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Mitochondrial uncoupling proteins regulate angiotensin-converting enzyme expression: crosstalk between cellular and endocrine metabolic regulators suggested by RNA interference and genetic studies

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Cytoplasmic mRNPs revisited: Singletons and condensates

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. RNA assemblages orchestrate complex cellular processes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The functional consequences of intron retention: Alternative splicing coupled to NMD as a regulator of gene expression

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Uncoupling proteins (UCPs) regulate mitochondrial function, and thus cellular metabolism. Angiotensin-converting enzyme (ACE) is the central component of endocrine and local tissue renin-angiotensin systems (RAS), which also regulate diverse aspects of whole-body metabolism and mitochondrial function (partly through altering mitochondrial UCP expression). We show that ACE expression also appears to be regulated by mitochondrial UCPs. In genetic analysis of two unrelated populations (healthy young UK men and Scandinavian diabetic patients) serum ACE (sACE) activity was significantly higher amongst UCP3-55C (rather than T) and UCP2 I (rather than D) allele carriers. RNA interference against UCP2 in human umbilical vein endothelial cells reduced UCP2 mRNA sixfold (P < 0·01) whilst increasing ACE expression within a physiological range (<1·8-fold at 48 h; P < 0·01). Our findings suggest novel hypotheses. Firstly, cellular feedback regulation may occur between UCPs and ACE. Secondly, cellular UCP regulation of sACE suggests a novel means of crosstalk between (and mutual regulation of) cellular and endocrine metabolism. This might partly explain the reduced risk of developing diabetes and metabolic syndrome with RAS antagonists and offer insight into the origins of cardiovascular disease in which UCPs and ACE both play a role.

OriginalsprogEngelsk
TidsskriftBioEssays
Vol/bind38 Suppl 1
Sider (fra-til)S107-18
ISSN0265-9247
DOI
StatusUdgivet - jul. 2016

ID: 48257631